These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

662 related articles for article (PubMed ID: 32276137)

  • 41. Coronavirus Disease (COVID-19) Pandemic: A Race Against Time.
    Banerjee AK; Arora N
    Curr Top Med Chem; 2020; 20(16):1434-1437. PubMed ID: 32282303
    [No Abstract]   [Full Text] [Related]  

  • 42. Potential therapeutic targets and promising drugs for combating SARS-CoV-2.
    Zhou H; Fang Y; Xu T; Ni WJ; Shen AZ; Meng XM
    Br J Pharmacol; 2020 Jul; 177(14):3147-3161. PubMed ID: 32368792
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A case of COVID-19 and pneumonia returning from Macau in Taiwan: Clinical course and anti-SARS-CoV-2 IgG dynamic.
    Lee NY; Li CW; Tsai HP; Chen PL; Syue LS; Li MC; Tsai CS; Lo CL; Hsueh PR; Ko WC
    J Microbiol Immunol Infect; 2020 Jun; 53(3):485-487. PubMed ID: 32198005
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COVID-2019: update on epidemiology, disease spread and management.
    Sahu KK; Mishra AK; Lal A
    Monaldi Arch Chest Dis; 2020 Apr; 90(1):. PubMed ID: 32297723
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Characteristics of the Multiplicity of Randomized Clinical Trials for Coronavirus Disease 2019 Launched During the Pandemic.
    Kouzy R; Abi Jaoude J; Garcia Garcia CJ; El Alam MB; Taniguchi CM; Ludmir EB
    JAMA Netw Open; 2020 Jul; 3(7):e2015100. PubMed ID: 32658285
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Audio Interview: Covid-19 and the President.
    Rubin EJ; Baden LR; Morrissey S
    N Engl J Med; 2020 Oct; 383(15):e104. PubMed ID: 33027580
    [No Abstract]   [Full Text] [Related]  

  • 47. COVID-19: Once upon a time in Portugal: A brief atlas of ongoing pandemic Portuguese research.
    Guimarães F; Winck JC
    Pulmonology; 2020; 26(5):257-258. PubMed ID: 32571675
    [No Abstract]   [Full Text] [Related]  

  • 48. Does the hygiene hypothesis apply to COVID-19 susceptibility?
    Sehrawat S; Rouse BT
    Microbes Infect; 2020 Oct; 22(9):400-402. PubMed ID: 32653475
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Preparedness and Preventive Behaviors for a Pandemic Disaster Caused by COVID-19 in Serbia.
    Cvetković VM; Nikolić N; Radovanović Nenadić U; Öcal A; K Noji E; Zečević M
    Int J Environ Res Public Health; 2020 Jun; 17(11):. PubMed ID: 32527056
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Antibody-dependent enhancement and COVID-19: Moving toward acquittal.
    Yager EJ
    Clin Immunol; 2020 Aug; 217():108496. PubMed ID: 32526272
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Convalescent plasma treatment for COVID-19: Tempering expectations with the influenza experience.
    Subbarao K; Mordant F; Rudraraju R
    Eur J Immunol; 2020 Oct; 50(10):1447-1453. PubMed ID: 32886952
    [TBL] [Abstract][Full Text] [Related]  

  • 52. China's successful control of COVID-19.
    Burki T
    Lancet Infect Dis; 2020 Nov; 20(11):1240-1241. PubMed ID: 33038941
    [No Abstract]   [Full Text] [Related]  

  • 53. Active Therapy with Passive Immunotherapy May Be Effective in the Fight against COVID-19.
    Morabito CJ; Gangadharan B
    Clin Transl Sci; 2020 Sep; 13(5):835-837. PubMed ID: 32420691
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical research protocol to evaluate the effectiveness and safety of individualized homeopathic medicine in the treatment and prevention of the COVID-19 epidemic.
    Teixeira MZ
    Rev Assoc Med Bras (1992); 2020 Apr; 66(4):405-406. PubMed ID: 32578770
    [No Abstract]   [Full Text] [Related]  

  • 55. Virology, Epidemiology, Pathogenesis, and Control of COVID-19.
    Jin Y; Yang H; Ji W; Wu W; Chen S; Zhang W; Duan G
    Viruses; 2020 Mar; 12(4):. PubMed ID: 32230900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. SARS-CoV-2: characteristics and current advances in research.
    Yang Y; Xiao Z; Ye K; He X; Sun B; Qin Z; Yu J; Yao J; Wu Q; Bao Z; Zhao W
    Virol J; 2020 Jul; 17(1):117. PubMed ID: 32727485
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rapid recovery of a SARS-CoV-2-infected X-linked agammaglobulinemia patient after infusion of COVID-19 convalescent plasma.
    Mira E; Yarce OA; Ortega C; Fernández S; Pascual NM; Gómez C; Alvarez MA; Molina IJ; Lama R; Santamaria M
    J Allergy Clin Immunol Pract; 2020 Sep; 8(8):2793-2795. PubMed ID: 32652231
    [No Abstract]   [Full Text] [Related]  

  • 58. "Early transfusion of convalescent plasma in older patients with COVID-19 to prevent disease progression: A structured summary of a study protocol for a randomised controlled trial".
    Teofili L; Landolfi R; Cingolani A; Antinori A; Vecchiet J; Sanguinetti M; Gasbarrini A; Pasciuto T; Orlando N; Lamonica S
    Trials; 2020 Oct; 21(1):875. PubMed ID: 33092632
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Suspending cross-team nursing care is necessary to prevent health care-associated infection during COVID-19 epidemic.
    Chen LC; Wu LK; Chen MH
    Kaohsiung J Med Sci; 2020 Nov; 36(11):955-956. PubMed ID: 32882107
    [No Abstract]   [Full Text] [Related]  

  • 60. Use of convalescent plasma in COVID-19 patients in China.
    Zhu M; Hu K; Zhu Z
    Transfus Clin Biol; 2020 Aug; 27(3):168-169. PubMed ID: 32425645
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 34.